Skin reactions to mRNA-1273 SARS-CoV-2 vaccine
QJM
.
2022 Dec 12;115(12):878.
doi: 10.1093/qjmed/hcac008.
Authors
Ruei-Lin Wang
1
,
Li-Yen Huang
2
3
,
Chung-Chi Yang
2
3
,
Chung-Yueh Hsieh
2
,
Kuo-An Wu
4
,
Jenq-Shyong Chan
5
6
,
Kun-Lin Wu
5
6
,
Hann-Yen Shyu
7
,
Yung-Hsi Kao
8
,
Shih-Ta Shang
9
,
Po-Jen Hsiao
5
6
8
Affiliations
1
From theDepartment of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
2
Division of Cardiology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
3
Division of Cardiology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
4
Division of Pulmonary & Critical Care Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
5
Division of Neurology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
6
Division of Nephrology, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
7
Division of Neurology, Department of Internal Medicine, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
8
Department of Life Sciences, National Central University, Taoyuan 320, Taiwan.
9
Division of Infectious Disease, Department of Internal Medicine, Taoyuan Armed Forces General Hospital, Taoyuan 325, Taiwan.
PMID:
35038738
PMCID:
PMC8807237
DOI:
10.1093/qjmed/hcac008
No abstract available
MeSH terms
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Humans
SARS-CoV-2
Substances
2019-nCoV Vaccine mRNA-1273
COVID-19 Vaccines